We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AIR:EURONEXT PARISAirbus SE Analysis

Data as of 2026-05-22 - not real-time

$108.44

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

AAR Corp. is trading below its short‑term moving averages while remaining above the long‑term trend line, indicating a neutral to slightly bearish technical stance. The RSI sits near the mid‑range and the MACD histogram is negative, reinforcing short‑term downside pressure despite an increasing volume trend. Fundamentally, revenue is growing robustly and the forward earnings estimate shows improvement, yet margins are modest and the balance sheet carries a high level of debt relative to equity. The company’s price‑to‑earnings multiple is comfortably below the industry average, suggesting a valuation edge, but the lack of dividend and limited cash reserves temper the upside. Recent news of a segment re‑organization and the winding down of a commercial unit has added short‑term uncertainty, contributing to a recent price dip.
Analyst sentiment is strongly positive, with a consensus “strong buy” and target prices implying a material upside. The high beta and elevated 30‑day volatility signal heightened market sensitivity, while the defense‑oriented business model provides a degree of defensive stability. Overall, the stock presents a blend of growth potential and value appeal, but investors should weigh the restructuring risk and leverage before committing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings miss and price decline
  • Bearish MACD and proximity to short‑term support
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth and improving forward EPS
  • Valuation discount to industry peers
  • Strategic segment restructuring aiming to lift margins

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained demand in aerospace and defense markets
  • Undervalued relative to earnings outlook
  • Potential for balance‑sheet de‑leverage as cash flow improves

Key Metrics & Analysis

Financial Health

Revenue Growth24.60%
Profit Margin5.46%
P/E Ratio23.6
ROE12.10%
ROA5.60%
Debt/Equity59.61
P/B Ratio2.6
Op. Cash Flow$94.8M
Free Cash Flow$27.9M
Industry P/E29.5

Technical Analysis

TrendNeutral
RSI46.9
Support$99.62
Resistance$121.59
MA 20$110.11
MA 50$111.84
MA 200$94.69
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

Fair Value$1.93
Target Price$131.67
Upside/Downside21.42%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.82
Volatility47.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.